Posted Sep. 6, 2013 at 10:15 a.m.

Premium Lock FDA: Lung drug from GSK and Theravance shows strong efficacy

Published: 2013-09-06 10:15:01
Updated: 2013-09-06 10:15:01

Lung disease Lung disease

Studies found the once-daily inhaled therapy, called Anoro Ellipta, works against chronic obstructive pulmonary disorder, though missing data may limit the reliability of the findings, Food and Drug Administration staff said today in a report....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 Bloomberg. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll